Kenro Hirata

ORCID: 0000-0003-4536-7781 · 2 papers in corpus
2020
·doi:10.21203/rs.2.21095/v1

Abstract Background Immune checkpoint inhibitors have been approved for various types of cancer; however, they cause a broad spectrum of immune-related adverse events (irAEs). The association between the development of irAEs and the clinic…

article 2011
·doi:10.1016/s0016-5085(11)63680-9